Tsp Capital Management Group, LLC Celldex Therapeutics, Inc. Transaction History
Tsp Capital Management Group, LLC
- $293 Million
- Q2 2025
A detailed history of Tsp Capital Management Group, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Tsp Capital Management Group, LLC holds 371,427 shares of CLDX stock, worth $9.6 Million. This represents 2.58% of its overall portfolio holdings.
Number of Shares
371,427
Previous 335,977
10.55%
Holding current value
$9.6 Million
Previous $6.1 Million
23.96%
% of portfolio
2.58%
Previous 2.18%
Shares
25 transactions
Others Institutions Holding CLDX
# of Institutions
198Shares Held
68.2MCall Options Held
219KPut Options Held
238K-
Kynam Capital Management, LP Princeton, NJ6.1MShares$158 Million14.83% of portfolio
-
Wellington Management Group LLP Boston, MA5.23MShares$135 Million0.02% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$121 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.96MShares$102 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.82MShares$98.7 Million0.01% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.21B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...